As CBD Oils Become More Popular, The FDA Considers Whether To Set New Rules
NPR
Allison Aubrey
May 31, 2019
The Food and Drug Administration is holding its first public hearing on CBD, the cannabis extract that has quickly grown into a billion-dollar industry. Today's hearing will help officials determine how to regulate CBD products.
"When the farm bill passed last year, we were beyond thrilled. This ended a multi-decade prohibition on hemp," says Jonathan Miller who serves as general counsel to the U.S. Hemp Roundtable, a coalition of dozens of hemp companies. "It was a historic moment." But the FDA quickly stepped in to make it clear that it has regulatory authority over CBD. The agency has said, for example, that cannabidiol products cannot be sold as dietary supplements. So the industry is asking for a more definitive set of rules, and the FDA hearing is a first step. "We really need the FDA to join in and help us lay a path toward a regulated legal product," Miller says. This is the main message he says he'll deliver during today's hearing.